Brian Powl
Corporate Officer/Principal bei KURA ONCOLOGY, INC.
Vermögen: 444 235 $ am 30.04.2024
Aktive Positionen von Brian Powl
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KURA ONCOLOGY, INC. | Corporate Officer/Principal | 14.08.2023 | - |
Karriereverlauf von Brian Powl
Ehemalige bekannte Positionen von Brian Powl
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CELGENE | Corporate Officer/Principal | - | - |
| FATE THERAPEUTICS, INC. | Corporate Officer/Principal | 30.06.2022 | - |
| MEI PHARMA, INC. | Vertrieb & Marketing | 15.09.2020 | - |
Ausbildung von Brian Powl
| University of California San Diego | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Corporate Officer/Principal | 3 |
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MEI PHARMA, INC. | Health Technology |
| FATE THERAPEUTICS, INC. | Health Technology |
| KURA ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Börse
- Insiders
- Brian Powl
- Erfahrung
